Skip to main content

Peer Review reports

From: Targeted therapies for ER+/HER2- metastatic breast cancer

Original Submission
12 Feb 2015 Submitted Original manuscript
Author responded Author comments
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 2
Submitted Manuscript version 2
Author responded Author comments
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
14 May 2015 Editorially accepted
9 Jun 2015 Article published 10.1186/s12916-015-0369-5

You can find further information about peer review here.

Back to article page